⭐️⭐️⭐️⭐️⭐️ "A total no brainer"

⭐️⭐️⭐️⭐️⭐️ "Love this, so easy."

Spots is the easy way to track your skin, mole and cancer changes.

Spots Global Cancer Trial Database for PET/CT Assessment of Tumor Perfusion in Patients With Renal Cell Carcinoma

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Trial Identification

Brief Title: PET/CT Assessment of Tumor Perfusion in Patients With Renal Cell Carcinoma

Official Title: PET/CT Assessment of Tumor Perfusion in Patients With Renal Cell Carcinoma

Study ID: NCT01502228

Study Description

Brief Summary: Given the growing importance of anti-angiogenic therapies in the treatment of metastatic renal carcinoma, it is expected that this trial will establish the preliminary data needed to apply for funding of a larger clinical investigation of the potential role of PET perfusion imaging in management of renal carcinoma, and potentially other cancers.

Detailed Description:

Keywords

Eligibility

Minimum Age: 18 Years

Eligible Ages: ADULT, OLDER_ADULT

Sex: ALL

Healthy Volunteers: No

Locations

Indiana University Simon Cancer Center, Indianapolis, Indiana, United States

Contact Details

Name: James Fletcher, M.D.

Affiliation: Indiana University, Radiology

Role: PRINCIPAL_INVESTIGATOR

Name: Theodore Logan, M.D.

Affiliation: Indiana University, Dept. Medicine (Hem/Onc)

Role: PRINCIPAL_INVESTIGATOR

Useful links and downloads for this trial

Clinicaltrials.gov

Google Search Results

Logo

Take Control of Your Skin and Body Changes Today.

Try out Spots for free, set up only takes 2 mins.

spots app storespots app store

Join others from around the world: